메뉴 건너뛰기




Volumn 35, Issue 4, 2012, Pages 255-256

Inadequate reporting of concomitant drug treatment in cardiovascular interventional head-to-head trials

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 84859764890     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.21958     Document Type: Review
Times cited : (7)

References (7)
  • 1
    • 61849104535 scopus 로고    scopus 로고
    • SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease
    • Serruys PW, Morice MC, Kappetein AP, et al. SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360: 961-972.
    • (2009) N Engl J Med. , vol.360 , pp. 961-972
    • Serruys, P.W.1    Morice, M.C.2    Kappetein, A.P.3
  • 2
    • 0027530879 scopus 로고
    • Coronary angioplasty versus coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) trial
    • Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet. 1993; 341: 573-580.
    • (1993) Lancet. , vol.341 , pp. 573-580
  • 3
    • 0028806673 scopus 로고
    • First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation)
    • CABRI Trial Participants
    • First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants. Lancet. 1995; 346: 1179-1184.
    • (1995) Lancet. , vol.346 , pp. 1179-1184
  • 4
    • 34247113737 scopus 로고    scopus 로고
    • Optimal medical therapy with or without PCI for stable coronary disease
    • Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1503-1516.
    • (2007) N Engl J Med. , vol.356 , pp. 1503-1516
    • Boden, W.E.1    O'Rourke, R.A.2    Teo, K.K.3
  • 5
    • 80052078304 scopus 로고    scopus 로고
    • Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial
    • Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart. 2011; 32: 2125-2134.
    • (2011) Eur Heart. , vol.32 , pp. 2125-2134
    • Kappetein, A.P.1    Feldman, T.E.2    MacK, M.J.3
  • 6
    • 34748897266 scopus 로고    scopus 로고
    • Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get with the Guidelines database
    • Hiratzka LF, Eagle KA, Liang L, et al. Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database. Circulation. 2007; 116 (11 suppl): I207-I212.
    • (2007) Circulation , vol.116 , Issue.SUPPL.11
    • Hiratzka, L.F.1    Eagle, K.A.2    Liang, L.3
  • 7
    • 79955494359 scopus 로고    scopus 로고
    • Coronary-artery bypass surgery in patients with left ventricular dysfunction
    • Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011; 364: 1607-1616.
    • (2011) N Engl J Med. , vol.364 , pp. 1607-1616
    • Velazquez, E.J.1    Lee, K.L.2    Deja, M.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.